These data suggest that TFPBC exhibited the best therapeutic efficacy with the highest expression of apoptosis marker cleaved caspase 3 and the lowest expression of tumor progressive markers P53 and Ki-67, and immune checkpoint protein PD-L1. The gene discussed is MKI67; the disease is neoplasm.